Personalis, Inc. Operating Lease, Expense
Personalis, Inc. (PSNL) reported Operating Lease, Expense of $1.40 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-11-04
- Personalis, Inc. operating lease, expense for the quarter ending 2021-09-30 was $1.40M, a 133.33% increase year-over-year.
- Personalis, Inc. operating lease, expense for the quarter ending 2021-06-30 was $700.00K, a 0.00% change year-over-year.
- Personalis, Inc. operating lease, expense for the quarter ending 2021-03-31 was $700.00K, a 133.33% increase year-over-year.
- Personalis, Inc. operating lease, expense for the quarter ending 2020-12-31 was $700.00K, a 133.33% increase year-over-year.
- Personalis, Inc. operating lease, expense for fiscal 2020 was $2.30M, a 109.09% increase from fiscal 2019.
- Personalis, Inc. operating lease, expense for fiscal 2019 was $1.10M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2021-09-30 | $1.40M 10-Q · filed 2021-11-04 | $2.10M derived: sum of 2 quarters · filed 2021-11-04 | $2.80M 10-Q · filed 2021-11-04 | $3.50M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | $700.00K 10-Q · filed 2021-08-04 | $1.40M 10-Q · filed 2021-08-04 | $2.10M derived: sum of 3 quarters · filed 2021-08-04 | $2.70M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | $700.00K 10-Q · filed 2021-05-05 | $1.40M derived: sum of 2 quarters · filed 2021-05-05 | $2.00M derived: sum of 3 quarters · filed 2021-11-04 | $2.70M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.30M derived: sum of 2 quarters · filed 2021-11-04 | $2.00M derived: sum of 3 quarters · filed 2021-11-04 | $2.30M 10-K · filed 2021-02-25 |
| 2020-09-30 | $600.00K 10-Q · filed 2021-11-04 | $1.30M derived: sum of 2 quarters · filed 2021-11-04 | $1.60M 10-Q · filed 2021-11-04 | $1.90M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $700.00K 10-Q · filed 2021-08-04 | $1.00M 10-Q · filed 2021-08-04 | $1.30M derived: sum of 3 quarters · filed 2021-08-04 | $1.60M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $300.00K 10-Q · filed 2021-05-05 | $600.00K derived: sum of 2 quarters · filed 2021-05-05 | $900.00K derived: sum of 3 quarters · filed 2021-05-05 | $1.20M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $600.00K derived: sum of 2 quarters · filed 2021-02-25 | $900.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.10M 10-K · filed 2021-02-25 |
| 2019-09-30 | $300.00K 10-Q · filed 2020-11-05 | $600.00K derived: sum of 2 quarters · filed 2020-11-05 | $800.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $300.00K 10-Q · filed 2020-08-06 | $500.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $200.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |